Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?

McIntyre DJ, Howe FA, Ladroue C, Lofts F, Stubbs M, Griffiths JR.

Open source

DOI
10.1007/s00280-010-1438-2
Published
2010-09-07
Container
Cancer Chemother Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-010-1438-2,
  title = {Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?},
  author = {McIntyre DJ and  Howe FA and  Ladroue C and  Lofts F and  Stubbs M and  Griffiths JR.},
  year = {2011},
  journal = {Cancer Chemother Pharmacol},
  doi = {10.1007/s00280-010-1438-2},
  url = {https://doi.org/10.1007/s00280-010-1438-2}
}

RIS

TY  - JOUR
TI  - Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?
AU  - McIntyre DJ
AU  -  Howe FA
AU  -  Ladroue C
AU  -  Lofts F
AU  -  Stubbs M
AU  -  Griffiths JR.
PY  - 2011
JO  - Cancer Chemother Pharmacol
DO  - 10.1007/s00280-010-1438-2
UR  - https://doi.org/10.1007/s00280-010-1438-2
ER  - 

APA

DJ, M., FA, H., C, L., F, L., M, S., & JR., G. (2011). Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-010-1438-2

Source records